100 related articles for article (PubMed ID: 20510691)
1. Peripheral exudative hemorrhagic chorioretinopathy: a clinical, angiographic, and histologic study.
Gonzales JA; Kapoor KG; Gibran SK
Am J Ophthalmol; 2010 Jun; 149(6):1013-4; author reply 1014. PubMed ID: 20510691
[No Abstract] [Full Text] [Related]
2. Peripheral exudative hemorrhagic chorioretinopathy: a clinical, angiographic, and histologic study.
Mantel I; Uffer S; Zografos L
Am J Ophthalmol; 2009 Dec; 148(6):932-8.e1. PubMed ID: 19800613
[TBL] [Abstract][Full Text] [Related]
3. Hemorrhagic detachment of the posterior pole.
Kotsolis AI; Karamchandani HK; Freund KB; Yannuzzi LA
Retina; 2009 Feb; 29(2):282-3. PubMed ID: 18784624
[No Abstract] [Full Text] [Related]
4. Peripheral exudative hemorrhagic chorioretinopathy: polypoidal choroidal vasculopathy and hemodynamic modifications.
Mantel I; Schalenbourg A; Zografos L
Am J Ophthalmol; 2012 May; 153(5):910-922.e2. PubMed ID: 22310077
[TBL] [Abstract][Full Text] [Related]
5. Peripheral polypoidal choroidal vasculopathy as a cause of peripheral exudative hemorrhagic chorioretinopathy: a report of 10 eyes.
Goldman DR; Freund KB; McCannel CA; Sarraf D
Retina; 2013 Jan; 33(1):48-55. PubMed ID: 22836900
[TBL] [Abstract][Full Text] [Related]
6. Correlation of indocyanine green angiography and optical coherence tomography findings after intravitreal ranibizumab for polypoidal choroidal vasculopathy.
Ueno C; Gomi F; Sawa M; Nishida K
Retina; 2012; 32(10):2006-13. PubMed ID: 22772392
[TBL] [Abstract][Full Text] [Related]
7. Angiographic changes after bevacizumab.
Ikuno Y; Soga K; Wakabayashi T; Gomi F
Ophthalmology; 2009 Nov; 116(11):2263.e1. PubMed ID: 19883861
[No Abstract] [Full Text] [Related]
8. Characterization of leakage activity in exudative chorioretinal disease with three-dimensional confocal angiography.
Teschner S; Noack J; Birngruber R; Schmidt-Erfurth U
Ophthalmology; 2003 Apr; 110(4):687-97. PubMed ID: 12689887
[TBL] [Abstract][Full Text] [Related]
9. Indocyanine green angiography of idiopathic polypoidal choroidal vasculopathy.
Phillips WB; Regillo CD; Maguire JI
Ophthalmic Surg Lasers; 1996 Jun; 27(6):467-70. PubMed ID: 8782261
[No Abstract] [Full Text] [Related]
10. Efficacy of intravitreal bevacizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy.
Gomi F; Sawa M; Wakabayashi T; Sasamoto Y; Suzuki M; Tsujikawa M
Am J Ophthalmol; 2010 Jul; 150(1):48-54.e1. PubMed ID: 20609707
[TBL] [Abstract][Full Text] [Related]
11. Relationship between clinical characteristics of polypoidal choroidal vasculopathy and choroidal vascular hyperpermeability.
Koizumi H; Yamagishi T; Yamazaki T; Kinoshita S
Am J Ophthalmol; 2013 Feb; 155(2):305-313.e1. PubMed ID: 23022162
[TBL] [Abstract][Full Text] [Related]
12. Intravitreous tissue plasminogen activator with pneumatic displacement in submacular hemorrhage.
Ratra D; Basia A
Arch Ophthalmol; 2012 Jun; 130(6):795-6. PubMed ID: 22801847
[No Abstract] [Full Text] [Related]
13. Clinical features and follow-up results of pulsating polypoidal choroidal vasculopathy treated with photodynamic therapy.
Byeon SH; Lew YJ; Lee SC; Kwon OW
Acta Ophthalmol; 2010 Sep; 88(6):660-8. PubMed ID: 19563374
[TBL] [Abstract][Full Text] [Related]
14. Resolution of subretinal haemorrhage and fluid after intravitreal bevacizumab in aggressive peripapillary subretinal neovascularization.
Soliman W; Lund-Andersen H; Larsen M
Acta Ophthalmol Scand; 2006 Oct; 84(5):707-8. PubMed ID: 16965507
[No Abstract] [Full Text] [Related]
15. Peripheral exudative hemorrhagic chorioretinopathy simulating choroidal melanoma in 173 eyes.
Shields CL; Salazar PF; Mashayekhi A; Shields JA
Ophthalmology; 2009 Mar; 116(3):529-35. PubMed ID: 19157563
[TBL] [Abstract][Full Text] [Related]
16. Giant retinal pigment epithelium rip in a patient with peripheral exudative hemorrhagic chorioretinopathy.
Kumar V; Tewari R
Indian J Ophthalmol; 2019 Jul; 67(7):1164-1165. PubMed ID: 31238439
[No Abstract] [Full Text] [Related]
17. Localizing polypoidal choroidal vasculopathy for laser treatment.
Bozzoni Pantaleoni F; Magliari Galante V; Da Dalt S; Pecorella I
Acta Ophthalmol Scand; 2007 Jun; 85(4):456-8. PubMed ID: 17263781
[No Abstract] [Full Text] [Related]
18. The indocyanine green findings in idiopathic uveal effusion syndrome.
Kumar A; Kedar S; Singh RP
Indian J Ophthalmol; 2002 Sep; 50(3):217-9. PubMed ID: 12355699
[TBL] [Abstract][Full Text] [Related]
19. One-year outcomes of intravitreal bevacizumab (avastin) therapy for polypoidal choroidal vasculopathy.
Cheng CK; Peng CH; Chang CK; Hu CC; Chen LJ
Retina; 2011 May; 31(5):846-56. PubMed ID: 21317837
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and therapeutic challenges.
Querques G; Lattanzio R; Querques L; Bandello F; Freund KB
Retina; 2013 Jan; 33(1):240-3. PubMed ID: 23095768
[No Abstract] [Full Text] [Related]
[Next] [New Search]
